Literature DB >> 12684448

Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons.

Shyam D Rao1, Hong Z Yin, John H Weiss.   

Abstract

Observations of elevated CSF glutamate in amyotrophic lateral sclerosis (ALS), together with findings that motor neurons are selectively vulnerable to glutamate receptor-mediated ("excitotoxic") injury, support an excitotoxic contribution to the motor neuron loss in the disease. However, the basis of the apparent loss of astrocytic glutamate transport capacity in affected areas of motor cortex and spinal cord, which probably underlies the extracellular glutamate elevations, is unexplained. Here, we find that glutamate induces far greater reactive oxygen species (ROS) generation in cultured motor neurons than in other spinal neurons. In addition, we found that the ROS seem to be able to leave the motor neurons and induce oxidation and disruption of glutamate uptake in neighboring astrocytes. Correspondingly, in a transgenic mouse model of ALS, protein oxidation was increased in regions immediately surrounding motor neurons. These results provide a mechanism that can account for the localized loss of glial glutamate transport seen in the disease. Furthermore, the observations lend support for a feedforward model involving reciprocal interactions between motor neurons and glia, which may prove useful in understanding ALS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684448      PMCID: PMC6742077     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

Review 1.  Oxidative stress in amyotrophic lateral sclerosis.

Authors:  W Robberecht
Journal:  J Neurol       Date:  2000-03       Impact factor: 4.849

2.  AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability.

Authors:  W Vandenberghe; E C Ihle; D K Patneau; W Robberecht; J R Brorson
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

3.  Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration.

Authors:  Y H Gong; A S Parsadanian; A Andreeva; W D Snider; J L Elliott
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

4.  AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro.

Authors:  S G Carriedo; S L Sensi; H Z Yin; J H Weiss
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

5.  Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase.

Authors:  G M Alexander; J S Deitch; J L Seeburger; L Del Valle; T D Heiman-Patterson
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

6.  Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients.

Authors:  Odile Spreux-Varoquaux; Gilbert Bensimon; Lucette Lacomblez; François Salachas; Pierre François Pradat; Nadine Le Forestier; Abdellatif Marouan; Michel Dib; Vincent Meininger
Journal:  J Neurol Sci       Date:  2002-01-15       Impact factor: 3.181

7.  Calcium dynamics and buffering in motoneurones of the mouse spinal cord.

Authors:  J Palecek; M B Lips; B U Keller
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

8.  Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis.

Authors:  S Sasaki; T Komori; M Iwata
Journal:  Acta Neuropathol       Date:  2000-08       Impact factor: 17.088

9.  Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.

Authors:  A Pramatarova; J Laganière; J Roussel; K Brisebois; G A Rouleau
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

10.  SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter.

Authors:  D Trotti; A Rolfs; N C Danbolt; R H Brown; M A Hediger
Journal:  Nat Neurosci       Date:  1999-05       Impact factor: 24.884

View more
  40 in total

1.  Targeting glial physiology and glutamate cycling in the treatment of depression.

Authors:  Gerald W Valentine; Gerard Sanacora
Journal:  Biochem Pharmacol       Date:  2009-04-17       Impact factor: 5.858

Review 2.  Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.

Authors:  Janos Paloczi; Zoltan V Varga; George Hasko; Pal Pacher
Journal:  Antioxid Redox Signal       Date:  2017-07-18       Impact factor: 8.401

3.  Marked synergism between mutant SOD1 and glutamate transport inhibition in the induction of motor neuronal degeneration in spinal cord slice cultures.

Authors:  Hong Z Yin; John H Weiss
Journal:  Brain Res       Date:  2012-02-09       Impact factor: 3.252

4.  Role of Astrocytes in Delayed Neuronal Death: GLT-1 and its Novel Regulation by MicroRNAs.

Authors:  Yi-Bing Ouyang; Lijun Xu; Siwei Liu; Rona G Giffard
Journal:  Adv Neurobiol       Date:  2014

5.  Intrathecal infusion of a Ca(2+)-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS.

Authors:  Hong Z Yin; Darryl T Tang; John H Weiss
Journal:  Exp Neurol       Date:  2007-07-24       Impact factor: 5.330

6.  Mutant SOD1 microglia-generated nitroxidative stress promotes toxicity to human fetal neural stem cell-derived motor neurons through direct damage and noxious interactions with astrocytes.

Authors:  Jason R Thonhoff; Junling Gao; Tiffany J Dunn; Luis Ojeda; Ping Wu
Journal:  Am J Stem Cells       Date:  2011-08-19

7.  Altered development in GABA co-release shapes glycinergic synaptic currents in cultured spinal slices of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Authors:  Manuela Medelin; Vladimir Rancic; Giada Cellot; Jummi Laishram; Priyadharishini Veeraraghavan; Chiara Rossi; Luca Muzio; Lucia Sivilotti; Laura Ballerini
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

8.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

9.  Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease.

Authors:  Manoj Kumar Jaiswal; Wolf-Dieter Zech; Miriam Goos; Christine Leutbecher; Alberto Ferri; Annette Zippelius; Maria Teresa Carrì; Roland Nau; Bernhard U Keller
Journal:  BMC Neurosci       Date:  2009-06-22       Impact factor: 3.288

10.  An in vitro screening cascade to identify neuroprotective antioxidants in ALS.

Authors:  Siân C Barber; Adrian Higginbottom; Richard J Mead; Stuart Barber; Pamela J Shaw
Journal:  Free Radic Biol Med       Date:  2009-01-30       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.